4
Changes in Ownership
Lyell Immunopharma, Inc. Filed Acc 0001209191-24-003276
Chief Business Officer acquired 50,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Lang Matthew · Chief Business Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-02-09 | Grant or award : show line 1 in the form | +50,000 | 50,000 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-02-09 | Grant or award : show line 2 in the form Option (right to buy) | +500,000 | 500,000 | D |
Loading xslF345X05/doc4.xml…